Literature DB >> 17452929

Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.

Wenjun Z Martini1, Michael A Dubick, Charles E Wade, John B Holcomb.   

Abstract

OBJECTIVE: To investigate the effect of tris-hydroxymethylaminomethane (THAM) pH neutralization on reversing coagulation abnormalities caused by acidosis.
DESIGN: Random and controlled study.
SETTING: Animal research facility and laboratory.
SUBJECTS: Yorkshire swine (n = 18).
INTERVENTIONS: Acidosis was induced in 12 pigs by infusing 0.2 M hydrochloric acid (HCl). When the target pH of 7.1 was achieved, the pigs were infused with either 0.3 M THAM to achieve pH of 7.4 (intervention group) or an equal volume of lactated Ringer's solution (acid control group).
MEASUREMENTS AND MAIN RESULTS: Blood samples were taken at baseline, 15 mins after reaching pH of 7.1, and 15 mins after THAM pH neutralization. Coagulation function was assessed by thrombin generation, prothrombin time, activated partial thromboplastin time, activated clotting time, and thromboelastography (maximum clot formation time [R+K], clotting rapidity [alpha], and clot strength [maximum amplitude]). An additional six pigs (sham group) were infused with THAM, and an equal volume of fluid as the 12 coagulopathic pigs was given to assess effects of THAM and hemodilution. Comparisons were made using a mixed model analysis of variance. No change in any indexes of coagulation was observed in sham pigs. Compared with baseline, acidosis of pH 7.1 decreased base excess from 6.6 +/- 0.5 mM to -12.4 +/- 0.5 mM; reduced fibrinogen levels to 72% +/- 2%, platelet counts to 53% +/- 3%, thrombin generation to 58% +/- 4%, alpha to 84% +/- 2%, and maximum amplitude to 75% +/- 3%; and prolonged prothrombin time to 113% +/- 2%, partial thromboplastin time to 122% +/- 4%, activated clotting time to 124% +/- 3%, and R + K to 119% +/- 3% (all p < .05). THAM infusion corrected pH to 7.40 +/- 0.02 and base excess to 2.6 +/- 0.9 mM (p < .05). However, there were no differences in thrombin generation, prothrombin time, partial thromboplastin time, activated clotting time, R+K, alpha, or maximum amplitude between the groups with or without pH correction.
CONCLUSIONS: Acidosis impaired coagulation by depleting clotting factors, inhibiting thrombin generation, and affecting clot strength and stability. THAM corrected acid-base deficit but did not acutely reverse the coagulation abnormalities in the model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452929     DOI: 10.1097/01.CCM.0000266682.74602.6A

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  Acidosis and correction of acidosis does not affect rFVIIa function in swine.

Authors:  Daniel N Darlington; Bijan S Kheirabadi; Michael R Scherer; Wenjun Z Martini; Michael A Dubick
Journal:  Int J Burns Trauma       Date:  2012-12-05

Review 2.  [Perioperative management of Jehovah's Witness patients. Special consideration of religiously motivated refusal of allogeneic blood transfusion].

Authors:  O Habler; B Voss
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

Review 3.  Posttraumatic massive bleeding: a challenging multidisciplinary task.

Authors:  Marco Marietta; Paola Pedrazzi; Massimo Girardis; Stefano Busani; Giuseppe Torelli
Journal:  Intern Emerg Med       Date:  2010-05-20       Impact factor: 3.397

4.  Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement.

Authors:  Manuel Muñoz; Jakob Stensballe; Anne-Sophie Ducloy-Bouthors; Marie-Pierre Bonnet; Edoardo De Robertis; Ino Fornet; François Goffinet; Stefan Hofer; Wolfgang Holzgreve; Susana Manrique; Jacky Nizard; François Christory; Charles-Marc Samama; Jean-François Hardy
Journal:  Blood Transfus       Date:  2019-02-06       Impact factor: 3.443

5.  In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.

Authors:  Alexander A Hanke; Stephanie Maschler; Herbert Schöchl; Felix Flöricke; Klaus Görlinger; Klaus Zanger; Peter Kienbaum
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-02-10       Impact factor: 2.953

6.  Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.

Authors:  H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman
Journal:  J Thromb Haemost       Date:  2015-09-22       Impact factor: 5.824

Review 7.  [Coagulation management in the treatment of multiple trauma].

Authors:  H Lier; H Krep; H Schöchl
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

Review 8.  [Prehospital resuscitation of patients with multiple injuries].

Authors:  M Winkelmann; M Wilhelmi
Journal:  Unfallchirurg       Date:  2014-02       Impact factor: 1.000

Review 9.  Coagulation complications following trauma.

Authors:  Wenjun Z Martini
Journal:  Mil Med Res       Date:  2016-11-22

10.  CO2 artificial pneumothorax on coagulation and fibrinolysis during thoracoscopic esophagectomy.

Authors:  Yunqin Ren; Hong Yan; Hengjiang Ge; Ji Peng; Han Zheng; Peng Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.